Viewing Study NCT06952803

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:32 PM
Ignite Modification Date: 2026-04-12 @ 3:59 PM
Study NCT ID: NCT06952803
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-04-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Localised/locally advanced prostate cancer View
None High-risk biochemical recurrence (BCR) View
None Poly (ADP-ribose) polymerase View
None Radiation therapy or radiotherapy View
None Breast cancer gene (BRCA) mutation View